ERASLAN, E. Et Al. 2018. Can Adropin and Preptin be a Prognostic Marker and a Potential Therapeutic Target in Prostate Cancer?. ACTA PHYSIOLOGICA , vol.225 , 33.

ERASLAN, E., TOPDAĞI, Ö., TANYELİ, A., GÜLER, M. C., Sebin, E., ÖZBEK ŞEBİN, S., ... Polat, E.(2018). Can Adropin and Preptin be a Prognostic Marker and a Potential Therapeutic Target in Prostate Cancer?. ACTA PHYSIOLOGICA , vol.225, 33.

ERASLAN, ERSEN Et Al. "Can Adropin and Preptin be a Prognostic Marker and a Potential Therapeutic Target in Prostate Cancer?," ACTA PHYSIOLOGICA , vol.225, 33, 2018

ERASLAN, ERSEN Et Al. "Can Adropin and Preptin be a Prognostic Marker and a Potential Therapeutic Target in Prostate Cancer?." ACTA PHYSIOLOGICA , vol.225, pp.33, 2018

ERASLAN, E. Et Al. (2018) . "Can Adropin and Preptin be a Prognostic Marker and a Potential Therapeutic Target in Prostate Cancer?." ACTA PHYSIOLOGICA , vol.225, p.33.

@article{article, author={ERSEN ERASLAN Et Al. }, title={Can Adropin and Preptin be a Prognostic Marker and a Potential Therapeutic Target in Prostate Cancer?}, journal={ACTA PHYSIOLOGICA}, year=2018, pages={33} }